In the media
Seqirus to build $800m flu vaccine facility in
Influenza vaccine provider Seqirus has announced plans to construct a world-class biotech manufacturing facility in Australia to supply influenza vaccines to Australia and the rest of the world (18 November 2020). More...
Wollongong Hospital finds solution to connect ICU
patients with their families
The hospital is mitigating the impact of ICU visitor restrictions with HowRU – a bespoke solution that uses video and collaboration technology to help families (17 November 2020). More...
Lifeblood Milk and SAHMRI partner to deliver
Australia's first breast milk fortifier for premature
Breast milk donated by Australian mothers will for the first time be used to create a "milk fortifier" prototype – a nutrient dense supplement that can help premature and low-weight babies grow (17 November 2020). More...
CSIRO solution creates smarter, safer homes for
Australia's national science agency, CSIRO, has developed a new health monitoring solution that will enable older Australians living independently at home to send real-time data to their healthcare providers (16 November 2020). More...
World-first skin cancer treatment aims to help
A new medication which can be applied to the skin could help prevent organ transplant recipients from developing harmful skin cancers. The world-first treatment being developed at The University of Queensland is the only drug of its type that could prevent the incidence of skin cancers for transplant patients (19 November 2020). More...
New drug research for prostate cancer could also fight
Two drugs under development to treat aggressive prostate cancer will now be tested to combat the deadliest response to COVID-19 infection – acute respiratory distress syndrome (16 November 2020). More...
This publication does not deal with every important topic or change in law and is not intended to be relied upon as a substitute for legal or other advice that may be relevant to the reader's specific circumstances. If you have found this publication of interest and would like to know more or wish to obtain legal advice relevant to your circumstances please contact one of the named individuals listed.